| P2093 | author name string | Abdulhadi Al-Zaben | |
| | Fawzi Abdel-Rahman | |
| | Ala'a Addasi | |
| | Ayad Hussein | |
| | Mohammad Aljamily | |
| | Nilly Hussein | |
| P2860 | cites work | Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD | Q28188441 |
| | The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse | Q34550152 |
| | High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients | Q34729066 |
| | Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group. | Q34746225 |
| | High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index | Q36135259 |
| | Brentuximab vedotin for the treatment of CD30+ lymphomas. | Q37861212 |
| | Autologous stem cell transplantation for refractory and relapsed Hodgkin's disease: factors predictive of prolonged survival | Q40683157 |
| | High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. | Q40906463 |
| | Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. | Q41041049 |
| | Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation | Q45159702 |
| | High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of p | Q45187568 |
| | Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. | Q54238415 |
| | Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease | Q69484546 |
| | The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients | Q70585679 |
| | High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant | Q70671897 |
| | Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results | Q71059744 |
| | A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curi | Q71611749 |
| | Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease | Q72037780 |
| | Patterns of survival in patients with Hodgkin's disease: long follow up in a single centre | Q72884034 |
| | Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease | Q73062516 |
| | High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes | Q81041884 |
| | High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver | Q81712987 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 249124 | |
| P577 | publication date | 2012-02-14 | |
| P1433 | published in | ISRN Oncology | Q26842194 |
| P1476 | title | High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables | |
| P478 | volume | 2012 | |